Stay updated with breaking news from Pharma Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Needham & Company LLC restated their buy rating on shares of NeoGenomics (NASDAQ:NEO – Get Rating) in a research report report published on Wednesday morning, Benzinga reports. They currently have a $21.00 target price on the medical research company’s stock. Other research analysts have also recently issued research reports about the stock. Morgan Stanley raised […]
MetLife Investment Management LLC raised its holdings in NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) by 1.7% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 66,436 shares of the medical research company’s stock after acquiring an additional 1,124 shares during the quarter. MetLife Investment Management […]
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT ... | April 5, 2023
Perkins Capital Management Inc. lifted its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) by 1.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 197,700 shares of the medical research company’s stock after purchasing an additional 2,150 shares during the quarter. NeoGenomics […]
TORONTO, April 4, 2023 /CNW/ - Think Research Corporation , a company focused on transforming healthcare through digital health software solutions, is pleased to announce that today it has... | April 4, 2023